
4.20 Delayed Data As of Dec 04 | ![]() Today’s Change | 3.35 Today|||52-Week Range 14.00 | -54.50% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $176.4M |
Stoke Therapeutics, Inc. 45 Wiggins Avenue Bedford Massachusetts 01730 |
Edward M. Kaye | Chief Executive Officer & Director |
Huw M. Nash | Chief Operating & Business Officer |
Stephen J. Tulipano | Chief Financial Officer |
Barry S. Ticho | Chief Medical Officer |
Isabel Aznarez | Group Vice President-Discovery Research |